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Aging	 is	 believed	 to	be	 a	 first-order	 risk	 factor	 for	most	neurodegenerative	disorders.	The	
neuronal	cell	loss	that	occurs	with	aging	has	been	partly	attributed	to	increased	production	of	
nitric	oxide	and	high	caspase	activity.	Melatonin	(MLT)	might	have	a	role	in	the	regulation	
of	nitric	oxide	 in	 the	brain.	We	 investigated	 the	effects	of	MLT	on	 the	nitrite/nitrate	 levels	
and	 caspase-3	 enzyme	 activity	 in	 the	 frontal	 cortex,	 temporal	 cortex,	 and	 hippocampus	 of	
young	 and	 aged	 rats.	There	was	 no	 significant	 difference	 between	 the	 nitrite	 levels	 in	 the	
frontal	cortex	and	hippocampus	of	young	and	aged	animals.	In	the	temporal	cortex	of	aged	
rats,	 the	 nitrite	 level,	 however,	 was	 significantly	 higher	 (P	 <	 0.001).	 In	 the	 aged	 group,	
MLT	 significantly	 decreased	 these	 levels	 in	 the	 brain	 regions.	 Caspase-3	 enzyme	 activity	
in	 the	 temporal	 and	 frontal	 cortices	 was	 significantly	 higher	 in	 aged	 rats	 when	 compared	
to	 the	 control	 group	 (P	 <	 0.05).	Melatonin	 did	 not	 cause	 significant	 changes	 in	 caspase-3	
activity	 in	 any	 brain	 region	 of	 both	 young	 and	 aged	 rats.	Thus,	 brain	 regions	 demonstrate	
different	caspase-3	enzyme	activities	and	nitrite	levels	in	the	aging	process.	Exogenous	MLT	
administration	 might	 delay	 brain	 aging	 (by	 moderation	 of	 death	 of	 neurons	 and	 glia)	 via	
decreasing	the	nitrite	level.
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INTRODUCTION
Aging	is	one	of	the	risk	factors	for	the	neurodegenerative	
diseases	 [1].	 Recently,	 it	 was	 reported	 that	 aging	
is	 accompanied	 by	 the	 development	 of	 some	
inflammatory	processes	at	the	tissue	level	in	different	
parts	 of	 the	 body	 and	 in	 the	 brain	 in	 particular	 [2].	
Aging	 intemsifies	 the	 glial	 cell	 activity	 in	 the	 brain	
[3],	and	 the	number	of	abnormal	astrocytes	 increases	
with	 aging	 [4].	The	 increased	 apoptotic	 cell	 death	of	
astrocytes	 observed	 in	 neurodegenerative	 diseases,	
such	 as	Alzheimer’s	 disease,	 is	 consistent	with	 these	
findings	[5].	Likewise,	increased	activity	of	caspase-3	
and	 caspase-9	 involved	 in	 the	 process	 of	 apoptosis	
has	been	reported	in	neurodegenerative	disorders,	like	
Alzheimer’s,	 Parkinson’s,	 and	 Huntington’s	 disease	
[6,	7].	
The	 existence	 of	 nitric	 oxide	 synthase	 (NOS)-
containing	neurons	in	the	cerebral	cortex,	cerebellum,	
hippocampus,	and	hypothalamus	suggests	a	possible	
role	of	nitric	oxide	(NO)	in	the	oxidative-antioxidative	
processes, 	 apoptosis, 	 and	 aging	 of	 the	 brain	 
[8,	9].	Nitric	oxide	can	behave	either	as	a	free-radical	
precursor	or	an	antioxidant	and	neuroprotective	agent	
[10].	 Depending	 on	 its	 local	 concentration	 and	 cell	
type,	NO	can	be	an	agent	promoting	either	apoptosis	
or	cell	 survival.	 Inhibition/induction	of	apoptosis	by	
NO	 is	mediated	 by	 downstream	 caspases,	 including	
caspase-3	[11]. 
Reactive	 oxygen	 and	 nitrogen	 species	 (ROSs	 and	
RONs),	 potent	 inducers	 of	 oxidative	 damage,	 have	
been	 shown	 to	 trigger	 apoptosis	 [12].	Accordingly,	
antioxidant	 treatment	 was	 shown	 to	 decrease	 the	
rate	 of	 this	 process	 [13].	 Superoxide	 and	 hydroxyl	
radicals	and	NO	might	also	be	related	to	aging	and,	in	
particular,	aging-related	loss	of	cognitive	functions	in	
humans	[14].	
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Melatonin	 (MLT)	 demonstrates	 a	 wide	 range	 of	
actions	 in	 different	 parts	 of	 the	 body,	 including	
effects	 on	 the	 circadian	 rhythm	 and	 neuroendocrine	
or	 immune	 functions	 [15-17].	 Melatonin	 and	 its	
metabolites	 are	 potent	 radical	 scavengers	 protecting	
cells	 from	damage	 induced	by	a	variety	of	oxidants,	
including	 hydroxyl	 radicals	 and	 lipid	 peroxidation	
products	 [18,	 19].	 Melatonin	 was	 also	 reported	 to	
suppress	increased	caspase	activity	in	the	liver	in	a	rat	
aging	model	 [20].	 	Likewise,	 it	was	shown	 that	MLT	
prevents	spontaneous	neuronal	apoptosis	by	inhibiting	
downstream	targets	of	Akt,	GSK3b,	and	FOXO-1	[15].	
In	 our	 study,	we	 aimed	 to	 investigate	 changes	 in	 the	
nitrate	levels	and	caspase-3	activity	in	different	brain	
regions	of	young	and	aged	rats	and	the	effects	of	MLT	
on	these	parameters.
METHODS
Animal Groups and Tissue Homogenization. A	
total	of	43	young	(4-month-old)	and	aged	(14-month-
old)	 male	Wistar	 albino	 rats	 was	 used	 in	 this	 study.	
The	 rats	 were	 divided	 into	 the	 control	 group	 
(10	animals	in	the	young	subgroup	and	10	ones	in	the	
aged	one)	and	the	melatonin	group	(10	animals	in	the	
young	 subgroup	 and	 13	 ones	 in	 the	 aged	 subgroup).	
While	 rats	of	 the	control	group	were	given	0.1	ml	of	
phosphate-buffered	saline	containing	1%	ethanol,	 the	
others	(melatonin	group)	were	injected	subcutaneously	
with	MLT	(Sigma	SM	5250,	USA)	at	a	dose	of	10	mg/kg	 
per	 day	 dissolved	 in	 0.1	 ml	 of	 phosphate-buffered	
saline	containing	1%	ethanol	for	7	days.	A	maximum	
of	 four	animals	were	kept	per	cage,	under	conditions	
of	 equal	 periods	 of	 light	 and	 dark	 (12/12	 h)	 in	 a	
room	with	lighting	control	(lights	on	at	08.00	and	off	 
at	 20.00).	 Injections	 were	 given	 daily	 at	 18.00,	 2	 h	
before	 the	 light	 was	 switched	 off,	 to	 compensate	 a	
presumed	 hormone	 deficiency	 in	 aged	 animals.	 	 On	
the	7th	day	of	the	experiment,	the	rats	were	sacrificed	
at	10.00,	and	brain	tissues	were	removed	and	dissected	
on	ice.	Tissue	samples	from	the	frontal	cortex,	temporal	
cortex,	and	hippocampus	were	kept	in	a	liquid	nitrogen	
tank	until	analysis.	 	
The	 samples	 were	 then	 homogenized	 in	 200	 μl	
of	 a	cell	 lysis	buffer	 (Promega,	USA)	using	a	 tissue	
homogenizer	 (Heidolph	 Diax	 900,	 Germany).	 The	
homogenate	 was	 centrifuged	 at	 16,000	 rpm	 for	 
15	 min	 at	 4°C,	 and	 protein	 concentrations	 in	 the	
cleared	 extracts	 were	 measured	 prior	 to	 storage	 at	
–86°C.	 Cleared	 extracts	 of	 the	 tissue	 homogenates	
were	assayed	for	caspase-3	activity.
Measurement of Caspase-3 Activity. In	 this	
study,	 we	 used	 the	 estimates	 of	 caspase-3	 activity	
as	 an	 indicator	 of	 caspase-dependent	 apoptosis.	The	
caspase-3	 activity	was	determined	by	a	 colorimetric	
assay	kit	 (Promega,	USA)	using	acetyl-Asp-Glu-Val-
Asp-p-nitroanilide	 (pNA)	 	as	 the	 substrate.	From	25	
to	100	μg	of	total	protein	of	the	clear	extracts	of	brain	
tissue	were	 used	 for	 the	 assay.	The	 specific	 caspase	
activity	 was	 expressed	 as	 picomoles	 yielding	 pNA	
per	microgram	of	protein	of	 the	supernatant	of	 tissue	
homogenates	[21].	
Measurement of the Total Nitrite Levels in the 
Brain Regions.	 The	 nitrite	 levels	 were	 measured	
using	an	enzyme-linked	 immunosorbent	assay	 reader	
by	 vanadium	 chloride	 (VCl3)/Griess	 assay.	 Prior	 to	
nitrite	 determination,	 tissues	 were	 homogenized	 in	
five	volumes	of	phosphate-buffered	saline	(pH	=	7.5)	
and	centrifuged	at	2,000g	for	5	min.	Then,	0.25	ml	of	
0.3	N	NaOH	was	added	 to	0.5	ml	of	 the	supernatant.	
After	 incubation	 for	 5	 min	 at	 room	 temperature,	 
0.25	 ml	 of	 5%	 (w/v)	 ZnSO
4
	 was	 added	 for	
deproteinization.	This	mixture	was	then	centrifuged	at	
3,000g	for	20	min,	and	supernatants	were	used	for	the	
assays	[22]. 
Statistical Analysis. Differences	 among	 the	
results	 obtained	 in	 the	 test	 groups	 were	 compared	
by	 one-way	ANOVA	and	 the	Mann–Whitney	U	 test.	
The	 Spearman’s	 test	 was	 used	 for	 nonparametric	
correlation	 analysis.	 Differences	 with	 two-sided	 
P	<	0.05	were	considered	to	be	significant. 
RESULTS
Exogenous MLT Decreases the Nitrite Level in the 
Cerebral Cortex. There	were	 significant	 differences	
between	 the	 nitrite	 levels	 in	 different	 brain	 regions	
of	 young	 and	 aged	 rats.	 The	 nitrite	 level	 in	 the	
frontal	 cortex	 was	 significantly	 higher	 than	 that	 in	
the	 temporal	 cortex	 and	 hippocampus	 of	 young	 rats	
(P	 =	 0.014	 and	 P	 <	 0.001,	 respectively).	 Likewise,	
the	 nitrite	 levels	 in	 the	 cortical	 regions	 (frontal	 and	
temporal	 cortices)	 in	 the	 aged	 group	 were	 higher	
than	 those	 in	 the	 hippocampus	 (P	 =	 0.043	 and	 P < 
0.001,	 respectively).	 No	 significant	 differences	 in	
the	above	levels	were	found	in	 the	frontal	cortex	and	
hippocampal	region	with	respect	to	age.	However,	the	
nitrite	 level	 in	 the	 temporal	 cortex	was	 significantly	
higher	compared	to	that	in	the	young	one	(P <	0.001)	
(Fig.	1,	Table	1).
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were	 close	 to	 each	 other	 in	 young	 rats	 (Fig.	 2,	 
Table	2).	Though	not	significant,	 the	enzyme	activity	
in	 the	 frontal	 cortex	 was	 the	 lowest	 among	 the	
studied	 brain	 regions	 in	 the	 young	 group.	However,	
the	 caspase-3	 activity	 in	 the	 temporal	 cortex	 was	
significantly	higher	than	that	in	the	frontal	cortex	and	
hippocampus	in	the	aged	group	(P	=	0.05	and	P	=	0.03,	
respectively;	Fig.	2).	
The	 age-related	 increase	 in	 caspase-3	 activity	 in	
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Fig. 1.	 Nitrite/nitrate	 levels	 in	 different	 brain	 regions	 of	 control	
(untreated)	groups	of	young	(1)	and	aged	(2)	rats.	***	Significant	
difference	with	P	<	0.001.
Рис. 1.	Рівні	нітритів/нітратів	в	різних	ділянках	мозку	контроль-
них	молодих	(1)	та	старих	(2)	щурів.
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Fig. 2.	Caspase-3	activity	 in	 сontrol	young	 (1)	 and	aged	 (2)	 rats.	
**Significant	difference	with	P	=	0.010;	***	the	same	with	P	<	0.002.	
Рис. 2.	Активність	каспази-3	в	різних	ділянках	мозку	контроль-
них	молодих	(1)	та	старих	(2)	щурів.
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TABLE 1. Nitrite/Nitrate Levels (µM) in Different Brain Regions of Assigned Rat Groups 
Т а б л и ц я 1. Рівні нітратів/нітритів (мкМ) у різних ділянках мозку щурів досліджених груп
Brain	regions
Young	rats P Aged	rats P
control melatonin control melatonin
Frontal	cortex 52.7	±	5.3 45.0	±	3.8 0.323 50.4	±	11.3 15.3	±	2.9 <0.001
Temporal	cortex 33.2	±	3.0 23.0	±	3.2 0.221 67.5	±	3.9 30.8	±	6.1 <0.001
Hippocampus 25.6	±	4.2 15.0	±	2.2 0.152 33.3	±	8.3 22.1	±	2.9 0.116
Footnote.	Means	±	s.e.m.	are	shown.
TABLE 2. Caspase-3 Activity (pmol/μg protein) in Different Brain Regions of Assigned Rat Groups
Т а б л и ц я 2. Активність каспази-3 (пмоль/мкг протеїну) у різних ділянках мозку щурів досліджених груп 
Brain	regions
Young P Aged P
control melatonin control melatonin
Frontal	cortex 		1.2	±	1.1 3.6	±	2.1 0.620 14.4	±	2.2 12.8	±	0.9 0.764
Temporal	cortex 		6.3	±	3.8 7.1	±	2.8 0.877 25.4	±	1.6 26.6	±	5.9 0.829
Hippocampus 4.96	±	2.7 5.7	±	2.5 0.866 			8.3	±	3.2 		4.9	±	1.1 0.465
Footnote.	Means	±	s.e.m.	are	shown.
Exogenous	 MLT	 caused	 insignificant	 decreases	
in	 the	 nitrite	 levels	 in	 young	 rats.	 Short-term	MLT	
treatment	 significantly	 decreased	 the	 nitrite	 level	
in	 cortical	 regions	 of	 aged	 rats,	 while	 a	 decrease	 in	
the	 hippo	campus	 was	 noticeable	 but	 not	 significant	 
(Table	1).	
Exogenous MLT and Caspase Activity in the 
Brain. We	found	that	the	levels	of	caspase-3	activity	in	
the	 frontal	cortex,	 temporal	cortex,	and	hippocampus	
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the	 frontal	 cortex	 was	more	 prominent	 than	 that	 in	
the	 temporal	 cortex	 (>	 10	 times	 and	 about	 4	 times,	
respectively).	 There	 was	 also	 a	 slight	 insignificant	
increase	in	the	caspase-3	activity	in	the	hippocampus	
with	aging	(Table	2,	Fig.2).
Short-term	 treatment	 with	 exogenous	 MLT	 caused	
no	 significant	 changes	 in	 caspase-3	 activity	 within	
different	 brain	 regions.	 Likewise,	 no	 significant	
change	in	the	levels	of	caspase-3	activity	in	the	cortical	
regions	and	hippocampus	of	the	aged	group	was	found	
after	such	treatment	(Table	2).
The	relationship	between	nitrite	levels	and	caspase-3	
activity	was	different	 in	 the	control	groups	of	young	
and	aged	rats.	While	there	was	a	considerable,	though	
statistically	insignificant	(r	=	–0.398;	P	=	0.083),	trend	
toward	 negative	 correlation	 between	 the	 nitrite	 and	
caspase-3	activity	 in	 the	young	group,	 the	analogous	
correlation	was	positive	in	the	aged	group	(r	=	0.315;	
P	=	0.253).
DISCUSSION
There	is	an	increased	incidence	of	abnormal	astrocytes	
during	aging.	Agents	such	as	IL-1	and	NO	produced	by	
those	abnormal	astrocytes	could	be	partly	responsible	
for	 general	 neuronal	 cell	 loss	 [23].	 The	 microglial	
cell	 activity	 is	 increased	 in	 both	 neurodegenerative	
diseases	 and	 aging	 [24].	 Reactive	 glial	 cells	 may	
intensify	the	oxidative	damage	in	the	brain.	Activated	
glial	cells	lead	to	a	more	intense		formation	of	ROSs,	
NO,	and	peroxynitrite-derived	radicals	[25].	Oxidative	
stress	 induces	 cognitive	 and	 motor	 deterioration	 by	
initiating	 inflammatory	processes	 in	 the	brain	during	
aging	 [26].	 Siles	 et	 al.	 [27]	 reported	 that	 different	
NOS	activities	 in	 the	 cerebral	 cortex	 and	 cerebellum	
are	age-dependent.	
The	 reports	 on	 the	 level	 of	NO	 and	NOS	 activity	
during	aging	are	contradictory	[28-30].	Liu	et	al.	[30]	
found	 that	an	 increased	eNOS	activity	was	observed	
in	 the	 hippocampus	 and	 dentate	 gyrus	 with	 aging,	
but	 changes	 in	 the	 areas	CA1	 and	CA3	 were	 mild.	
Likewise,	Blanco	et	al.	 [31]	observed	no	age-related	
difference	in	the	nitrite	level	in	the	cerebellum.	In	our	
study,	we	 found	 that	 the	nitrite	 level	 in	 the	 temporal	
cortex	increases	with	aging,	but	this	was	not	the	case	
in	 the	 frontal	 cortex	 and	 hippocampus	 (Fig.	 2).	The	
microglial	activity	 in	 the	 temporal	 lobe	was	 reported	
to	 increase	 with	 aging,	 which	 is	 associated	 with	
neuronal	 loss	 in	 the	 temporal	cortex	and	a	cognitive	
function	decrease	[32,	33].	Accordingly,	an	increased	
pro-oxidant	cytokine	production	in	mouse	brain	tissues	
induced	 by	 lipopolysaccharides	 was	 found	 during	
aging	[34].
Melatonin,	 the	 chief	 secretory	 product	 of	 the	
epiphysis	 (pineal	 gland)	 is	 an	 efficient	 free-radical	
scavenger	 in	 the	 body	 and	 brain.	 By	 preventing	
oxidative	 damage,	 MLT	 reduces	 the	 intensity	 of	
apoptosis	 of	 neurons	 and	 glial	 cells	 [35].	 In	 our	
experiments,	we	found	that	short-term	exogenous	MLT	
treatment	significantly	decreases	 the	nitrite	 levels	 in	
the	cortical	regions	but	not	in	the	hippocampus	of	aged	
rats	(Table	1).
Increased	apoptosis	 in	various	 tissues	of	 the	body	
is	one	of	 the	hallmarks	of	 the	aging	process.	Earlier,	
we	and	others	found	that	caspase	activity	in	the	liver,	
lungs,	 spleen,	 and	 	 gastric	 mucosa	 increased	 with	
aging	 [36,	37].	As	well,	 increased	caspase-3	activity	
in	 cortical	 regions	 of	 the	 brain	 	 during	 aging	 was	
shown	previously	 [38].	The	caspase-3	activity	 in	 the	
hippocampus	was	 reported	 to	 increase	 significantly	
in	 old	 individuals	 when	 compared	 to	 that	 in	 young	
ones	 [23].	We,	however,	 could	not	 find	a	 significant	
increase	in	the	caspase-3	activity	in	the	hippocampus	
with	 aging	 (Table	 2).	 Instead,	 we	 found	 significant	
increases	 in	 the	 enzyme	 activity	 in	 the	 cerebral	
cortices	in	the	current	study.
Melatonin	 has	 been	 shown	 to	 inhibit	 caspase-3	
activity	 and	 JNK-mediated	 cell	 death	 of	 neurons	
induced	by	the	action	of	a	neurotoxin	[39].	We	showed	
earlier	that	1-week-long	treatment	with	MLT	decreased	
the	 caspase-3	 level	 in	 the	 gastrointestinal	 system	
[36].	In	our	study,	however,	we	found	that	short-term	 
(1	week)	 introduction	of	exogenous	MLT	exerted	no	
significant	effect	on	the	increased	caspase-3	activity	in	
the	brain	regions	of	aged	rats.	The	discordance	of	the	
effects	of	MLT	on	nitrite	levels	and	caspase-3	activity	
in	the	brain	might	be	related	to	the	short-term	action	of	
the	drug	(1	week).		Therefore,	testing	of	the	effects	of	
prolonged	administration	of	MLT	on	caspase	activity	
in	brain	tissues	would	be	a	subject	of	another	study.
Our	 results	 suggest	 that	 exogenous	MLT	provides	
effective	free-radical	scavenging	in	the	cerebral	cortex	
of	 rats.	 One-week-long	 MLT	 treatment,	 however,	
seems	 insufficient	 to	 decrease	 neuronal	 or	 glial	
apoptosis	mediated	by	caspase-3.
The	study	was	carried	out	 in	accordance	with	the	internationly	
accepted	ethical	principles.
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Р	е	з	ю	м	е
В	аспекті	розвитку	нейродегенеративних	розладів	старіння	
розглядається	як	фактор	ризику	першого	порядку.	Втрату	не-
рвових	клітин,	яка	відбувається	з	віком,	пов’язували,	в	уся-
кому	разі	частково,	зі	 збільшенням	продукції	оксиду	азоту	
та	високій	активності	каспаз.	Мелатонін	(МТ)	може	відігра-
вати	певну	роль	у	регуляції	рівня	оксиду	азоту	в	мозку.	Ми	
досліджували	впливи	МТ	на	рівні	нітритів/нитратів	та	ензи-
матичну	активність	каспази-3	у	фронтальній	і	темпоральній	
корі	та	гіпокампі	молодих	і	старих	щурів.	Істотних	відмін-
ностей	між	рівнями	нітритів	у	фронтальній	корі	та	гіпокам-
пі	молодих	і	старих	тварин	виявлено	не	було,	проте	цей	рі-
вень	в	темпоральній	корі	старих	тварин	був	істотно	вищим	 
(P	<	0.001).	У	групі	старих	щурів	МТ	істотно	знижував	рівні	
нітритів	в	структурах	мозку.	Активність	каспази-3	у	фрон-
тальних	 і	темпоральних	зонах	кори	старих	щурів	була	до-
стовірно	вище,	ніж	у	контрольних	тварин	(P	<	0.05).	Мела-
тонін	не	викликав	істотних	змін	активності	каспази-3	у	всіх	
досліджених	структурах	мозку	як	молодих,	так	і	старих	щу-
рів.	Отже,	рівні	активності	каспази-3	та	концентрації	нітри-
тів	в	різних	структурах	мозку	в	перебігу	процесу	старіння	
демонструють	певну	специфічність.	Вплив	екзогенного	МТ,	
мабуть,	затримує	старіння	мозку	(зменшуючи	інтенсивність	
загибелі	нейронів	і	глії)	за	рахунок	зниження	рівнів	нітриту.	
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